Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05848947 · ClinicalTrials.gov registry record · Phase 4
SIR-Spheres Study to Calculate the Radiation-Absorbed Dose of 99mTc-MAA
A Phase 4 study, sponsored by Sirtex Medical.
- Completed
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
NCT05848947 is a Phase 4 study that has completed, run by Sirtex Medical. The registered enrollment target is 5 participants.
The verdict
NCT05848947, a Phase 4 study, has completed, sponsored by Sirtex Medical.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
Study Summary
The goal of this interventional clinical trial is to evaluate the dose of radiation of Technetium-99m macroaggregated-albumin (99mTc-MAA) after an intra-arterial injection to the whole body and non-liver critical organs in patients who are undergoing evaluation for SIR-Spheres treatment for hepatocellular carcinoma.
Interventions
- DRUG 99mTc-Macro Albumin Aggregate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2023-04-25 |
| Est. Completion | 2023-07-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05848947
The ClinicalTrials.gov registry entry for NCT05848947 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sirtex Medical, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 99mTc-Macro Albumin Aggregate is the first listed.
NCT05848947 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05848947 about?
NCT05848947 is a clinical study titled "SIR-Spheres Study to Calculate the Radiation-Absorbed Dose of 99mTc-MAA". The goal of this interventional clinical trial is to evaluate the dose of radiation of Technetium-99m macroaggregated-albumin (99mTc-MAA) after an intra-arterial injection to the whole body and non-liver critical organs in patients who are undergoing evaluation for SIR-Spheres treatment for hepatoce...
What is the current status of trial NCT05848947?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2023-04-25. Estimated completion is 2023-07-05.
What interventions are being tested in trial NCT05848947?
The interventions under investigation include: 99mTc-Macro Albumin Aggregate (DRUG).
Who is sponsoring clinical trial NCT05848947?
This trial is sponsored by Sirtex Medical, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.